ArticleNeuro-oncology2018

Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells.

Nusrat Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.